Cargando…

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack

Background: Although ticagrelor plus aspirin is more effective than aspirin alone in preventing the 30-day risk of a composite of stroke or death in patients with an acute mild-to-moderate ischemic stroke (IS) or transient ischemic attack (TIA), the cost-effectiveness of this combination therapy rem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jigang, Ji, Linjin, Tong, Xin, Han, Mingyang, Zhao, Songfeng, Qin, Yongkai, He, Zilong, Jiang, Zhiqun, Liu, Aihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971565/ https://www.ncbi.nlm.nih.gov/pubmed/35370758 http://dx.doi.org/10.3389/fphar.2022.790048

Ejemplares similares

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Ticagrelor plus aspirin in patients with minor ischemic stroke and transient ischemic attack: a network meta-analysis
por: Li, Mingxia, et al.
Publicado: (2023)

Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin
por: Amarenco, Pierre, et al.
Publicado: (2020)

Time Course for Benefit and Risk of Ticagrelor and Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack
por: Wang, Yongjun, et al.
Publicado: (2022)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Cost-Effectiveness of Short-Course Radiation Plus Temozolomide for the Treatment of Newly Diagnosed Glioblastoma Among Elderly Patients in China and the United States
por: Chen, Jigang, et al.
Publicado: (2021)

Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
por: Tank, Amarjeet, et al.
Publicado: (2023)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

Ticagrelor Added to Aspirin in Acute Ischemic Stroke or Transient Ischemic Attack in Prevention of Disabling Stroke: A Randomized Clinical Trial
por: Amarenco, Pierre, et al.
Publicado: (2020)

The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design
por: Johnston, S Claiborne, et al.
Publicado: (2019)

Ticagrelor vs Clopidogrel in addition to Aspirin in minor ischemic stroke/ transient ischemic attack—Protocol for a systematic review and network meta-analysis
por: Zitikyte, Gabriele, et al.
Publicado: (2021)

Panax notoginseng preparation plus aspirin versus aspirin alone on platelet aggregation and coagulation in patients with coronary heart disease or ischemic stroke: A meta-analysis of randomized controlled trials
por: Dai, Lulu, et al.
Publicado: (2022)

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016)

Cost-effective analysis of mechanical thrombectomy alone in the treatment of acute ischaemic stroke: a Markov modelling study
por: Han, Mingyang, et al.
Publicado: (2022)

Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial
por: Wang, Yilong, et al.
Publicado: (2019)

Effectiveness of cilostazol in transient ischemic attack refractory to aspirin: A report of two cases
por: LIN, GAOPING, et al.
Publicado: (2014)

Efficacy and safety of clopidogrel and/or aspirin for ischemic stroke/transient ischemic attack: An overview of systematic reviews and meta-analysis
por: Yang, Youwen, et al.
Publicado: (2021)

Clopidogrel plus aspirin versus aspirin alone for acute minor ischaemic stroke or high risk transient ischaemic attack: systematic review and meta-analysis
por: Hao, Qiukui, et al.
Publicado: (2018)

Platelet-Mediated Transfer of Cardioprotection by Remote Ischemic Conditioning and Its Abrogation by Aspirin But Not by Ticagrelor
por: Lieder, Helmut Raphael, et al.
Publicado: (2022)

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial
por: Zhou, Mengyuan, et al.
Publicado: (2020)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
por: Chen, Ying, et al.
Publicado: (2022)

Low platelet reactivity in patients with myocardial infarction treated with aspirin plus ticagrelor
por: Costa, Thiago Guarato Rodrigues, et al.
Publicado: (2022)

The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized Trials
por: Lei, Hong, et al.
Publicado: (2016)

Efficacy and Safety of Ticagrelor and Aspirin in Patients With Moderate Ischemic Stroke: An Exploratory Analysis of the THALES Randomized Clinical Trial
por: Wang, Yongjun, et al.
Publicado: (2021)

Transient ischemic attacks: predictability of future ischemic stroke or transient ischemic attack events
por: Gupta, Harsh V, et al.
Publicado: (2014)

Beneficial Effect of Beraprost Sodium Plus Aspirin in the Treatment of Acute Ischemic Stroke
por: Chen, Siqia, et al.
Publicado: (2017)

Long Non-Coding RNA H19 Positively Associates With Aspirin Resistance in the Patients of Cerebral Ischemic Stroke
por: Wang, Jue, et al.
Publicado: (2020)

SHR2285, the first selectively oral FXIa inhibitor in China: Safety, tolerability, pharmacokinetics and pharmacodynamics combined with aspirin, clopidogrel or ticagrelor
por: Ma, Tingting, et al.
Publicado: (2022)

Differentiation of true transient ischemic attack versus transient ischemic attack mimics
por: Noureddine, Ali, et al.
Publicado: (2014)

A systematic review and meta-analysis of published randomized controlled trials of combination of clopidogrel and aspirin in transient ischemic attack or minor stroke
por: Zhou, Xingjian, et al.
Publicado: (2017)

Combined impact of body mass index and glycemic control on the efficacy of clopidogrel-aspirin therapy in patients with minor stroke or transient ischemic attack
por: Chen, Zimo, et al.
Publicado: (2020)

Economic evaluation of intravenous alteplase for stroke with the time of onset between 4.5 and 9 hours
por: Chen, Jigang, et al.
Publicado: (2023)

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
por: Schmaier, Alec A., et al.
Publicado: (2018)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in Patients with Coronary and Peripheral Artery Diseases in Italy
por: Ferrara, Pietro, et al.
Publicado: (2021)

Camptocormia with Transient Ischemic Attack
por: Oh, Ju-Hee, et al.
Publicado: (2017)

Headache in transient ischemic attacks
por: Lebedeva, Elena R., et al.
Publicado: (2018)

Aspirin resistance and ischemic heart disease on Iranian experience
por: Sadeghi, Masoumeh, et al.
Publicado: (2012)

Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis
por: Yao, Jia-Chen, et al.
Publicado: (2018)

Mechanism of Improving Aspirin Resistance: Blood-Activating Herbs Combined With Aspirin in Treating Atherosclerotic Cardiovascular Diseases
por: Zhao, Yixi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ghnfvj7q0gk0jtovirgbl2h1ur